Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function

Frontiers in Aging Neuroscience - Switzerland
doi 10.3389/fnagi.2018.00121
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

In Vivo Mitochondrial Function in Idiopathic and Genetic Parkinson’s Disease

Metabolites
BiochemistryEndocrinologyMetabolismMolecular BiologyDiabetes
2019English

Optogenetic Regulation of Mitochondrial Function and Synaptic Plasticity in Vivo

Biophysical Journal
Biophysics
2019English

Regulation of Proline 3-Hydroxylation and Prolyl 3-Hydroxylase and 4-Hydroxylase Activities in Transformed Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1982English

Mitochondrial Redox State as a Potential Detector of Liver Dysoxia in Vivo

Journal of Applied Physiology
MedicinePhysiologySports Science
1998English

The -Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential

Journal of Neuroscience
Neuroscience
2009English

Role of Prolyl Hydroxylase Domain Proteins in the Regulation of Insulin Secretion

Physiological Reports
Physiology
2016English

Thioredoxin Glutathione Reductase: Its Role in Redox Biology and Potential as a Target for Drugs Against Neglected Diseases

Biochimica et Biophysica Acta - General Subjects
BiochemistryMolecular BiologyBiophysics
2011English

Effects of Mid-Respiratory Chain Inhibition on Mitochondrial Function in Vitro and in Vivo

Toxicology Research
MutagenesisToxicologyHealth
2016English

A Potent Prolyl Hydroxylase Inhibitor, P-1894b, Produced by a Strain of Streptomyces.

Journal of Antibiotics
Drug DiscoveryPharmacology
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy